These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 15929805)

  • 1. Immunologic therapies for gastrointestinal cancers.
    Levy B; Deeken JF; Holt G; Marshall JL
    Clin Colorectal Cancer; 2005 May; 5(1):37-49. PubMed ID: 15929805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination therapy in malignant disease.
    Aloysius MM; Robins RA; Eremin JM; Eremin O
    Surgeon; 2006 Oct; 4(5):309-20. PubMed ID: 17009550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy offers a promising bet against brain cancer.
    Eisenstein M
    Nature; 2018 Sep; 561(7724):S42-S44. PubMed ID: 30258155
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer vaccines: an update.
    Hipp JD; Hipp JA; Lyday BW; Minev BR
    In Vivo; 2000; 14(5):571-85. PubMed ID: 11125541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine strategies for glioblastoma: progress and future directions.
    Jackson C; Ruzevick J; Brem H; Lim M
    Immunotherapy; 2013 Feb; 5(2):155-67. PubMed ID: 23413907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for gastrointestinal malignancies.
    Toomey PG; Vohra NA; Ghansah T; Sarnaik AA; Pilon-Thomas SA
    Cancer Control; 2013 Jan; 20(1):32-42. PubMed ID: 23302905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for pancreatic cancer: current concepts.
    Kaufman HL; Di Vito J; Hörig H
    Hematol Oncol Clin North Am; 2002 Feb; 16(1):159-97, viii. PubMed ID: 12063825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carcinoembryonic antigen transgenic mouse models for immunotherapy and development of cancer vaccines.
    Bhattacharya-Chatterjee M; Saha A; Foon KA; Chatterjee SK
    Curr Protoc Immunol; 2008 Feb; Chapter 20():20.8.1-20.8.12. PubMed ID: 18432635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of metastasis.
    Dallal RM; Lotze MT
    Surg Oncol Clin N Am; 2001 Apr; 10(2):433-47, xi. PubMed ID: 11382596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered dendritic cells for gastrointestinal tumor immunotherapy: opportunities in translational research.
    Bhargava A; Mishra D; Banerjee S; Mishra PK
    J Drug Target; 2013 Feb; 21(2):126-36. PubMed ID: 23061479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New era of tumor immunotherapy].
    Yoshitake Y; Nakatsura T; Nishimura Y
    Nihon Rinsho; 2005 Apr; 63 Suppl 4():46-55. PubMed ID: 15861634
    [No Abstract]   [Full Text] [Related]  

  • 12. MUC1 immunotherapy.
    Beatson RE; Taylor-Papadimitriou J; Burchell JM
    Immunotherapy; 2010 May; 2(3):305-27. PubMed ID: 20635898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical applications of a peptide-based vaccine for glioblastoma.
    Kanaly CW; Ding D; Heimberger AB; Sampson JH
    Neurosurg Clin N Am; 2010 Jan; 21(1):95-109. PubMed ID: 19944970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-HER2 vaccines: The HER2 immunotargeting future?].
    Ladjemi MZ; Jacot W; Pèlegrin A; Navarro-Teulon I
    Pathol Biol (Paris); 2011 Jun; 59(3):173-82. PubMed ID: 19481373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas.
    Ueda Y; Itoh T; Nukaya I; Kawashima I; Okugawa K; Yano Y; Yamamoto Y; Naitoh K; Shimizu K; Imura K; Fuji N; Fujiwara H; Ochiai T; Itoi H; Sonoyama T; Hagiwara A; Takesako K; Yamagishi H
    Int J Oncol; 2004 Apr; 24(4):909-17. PubMed ID: 15010829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted Immunotherapies in Gastrointestinal Cancer: From Molecular Mechanisms to Implications.
    Wang DK; Zuo Q; He QY; Li B
    Front Immunol; 2021; 12():705999. PubMed ID: 34447376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cells: tools and targets for antitumor vaccination.
    den Brok MH; Nierkens S; Figdor CG; Ruers TJ; Adema GJ
    Expert Rev Vaccines; 2005 Oct; 4(5):699-710. PubMed ID: 16221071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases].
    Alfaro C; Murillo O; Tirapu I; Azpilicueta A; Huarte E; Arina A; Arribillaga L; Pérez-Gracia JL; Bendandi M; Prieto J; Lasarte JJ; Melero I
    An Sist Sanit Navar; 2006; 29(1):77-96. PubMed ID: 16670731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of tumor vaccines in GI malignancies.
    Laheru DA; Jaffee EM
    Oncology (Williston Park); 2000 Feb; 14(2):245-56; discussion 259-60, 265. PubMed ID: 10736811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell epitope peptide vaccines.
    Elsawa SF; Rodeberg DA; Celis E
    Expert Rev Vaccines; 2004 Oct; 3(5):563-75. PubMed ID: 15485336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.